Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xeplion 100mg/1ml prolonged-release inj pf syringes
0402020ABBBACAC
|
Xeplion | Paliperidone | Central Nervous System | 118 |
|
Xeplion 150mg/1.5ml prolonged-release inj pf syringes
0402020ABBBADAD
|
Xeplion | Paliperidone | Central Nervous System | 94 |
|
Xeplion 75mg/0.75ml prolonged-release inj pf syringes
0402020ABBBABAB
|
Xeplion | Paliperidone | Central Nervous System | 81 |
|
Xeplion 50mg/0.5ml prolonged-release inj pf syringes
0402020ABBBAAAA
|
Xeplion | Paliperidone | Central Nervous System | 37 |
|
Xeplion 150mg/1.5ml and 100mg/1ml treatment initiation pack
0402020ABBBAEAE
|
Xeplion | Paliperidone | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.